MedTrace Logo

Low-Level Laser Therapy and Injectable Platelet-Rich Fibrin for Thin Gingival Phenotype.

NCT06756854 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2025-01-03

No results posted yet for this study

Summary

Management of thin gingival phenotype using non-surgical methods (injection of liquid platelet rich fibrin and exposure to low level laser therapy

Conditions

  • Periodontal Diseases

Interventions

BIOLOGICAL

Biologic Agent: injectable platelet rich fibrin.

injection of I-PRF to thin gingival phenotype 3 times with 7 days interval between sessions.

OTHER

injecable platelet rich fibrin, and low level laser therapy radiation.

injection of I-PRF+ exposure to LLLT to thin gingival phenotype 3 times with 7 days interval between sessions.

Sponsors & Collaborators

  • Faculty of Dental Medicine for Girls

    lead OTHER_GOV

Principal Investigators

  • Ahmed Eldawy, doctor · MINDRAY

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-12
Primary Completion
2024-05-14
Completion
2024-06-15
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06756854 on ClinicalTrials.gov